Clinical Trial Update: ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ACHP-THP to EC-THP as neoadjuvant therapy for HER2-positive early breast cancer (EBC); status ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ACHP-THP
• EC-THP

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer, Neoadjuvant Chemotherapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING